What question did this study set out to answer?

The aim is to understand how tumors evade immune responses and to explore strategies to overcome this resistance.

July 6, 2026Discover OncologyOpen Access

Tumor-induced immune escape mechanisms and translational immunotherapeutic strategies

View Full Paper

Ask AI

Bookmark

Authors

Examines immune evasion in cancer and assesses innovative immunotherapy strategies to improve treatment outcomes.

The aim is to understand how tumors evade immune responses and to explore strategies to overcome this resistance.
Comprehensive assessment of tumor-induced immune evasion mechanisms and therapeutic strategies.
Analysis of immune checkpoint blockade, CAR-T cell therapy, cancer vaccines, and oncolytic virotherapy.
Evaluation of predictive biomarkers like PD-L1 and Tumor Mutational Burden to personalize immunotherapy.
Identification of multiple immune evasion strategies employed by tumors, leading to therapeutic resistance.
Highlighting the importance of combinatorial approaches and TME reprogramming in enhancing immunotherapy efficacy.
Promotion of predictive biomarkers to guide individualized treatment plans for enhanced patient responses.

Yousefi et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark